Mechanism
EGFR (mutant, incl. L858R/T790M) and BTK
Assets acting on this target.
- Class
- Dual EGFR/BTK tyrosine kinase inhibitor
- Pathway
- ATP-competitive binding to mutant EGFR and BTK blocks downstream PI3K/AKT and MAPK signaling
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.